Daniel Molin

Associate Professor

Uppsala University

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Immunology Immunology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

Joshua Philipp Entrop

Karolinska Institutet

SWEDEN

View details

Ingrid Glimelius

SWEDEN

View details

Rose-Marie Amini

SWEDEN

View details

Sara Ek

SWEDEN

View details

Harald Holte

Senior consultant, head of lymphoma section

University of Oslo

NORWAY

View details

John Radford

The University of Manchester

UNITED KINGDOM

View details

Anna Porwit

Professor

Lund University

SWEDEN

View details

Martin Hutchings

Professor

University of Copenhagen

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daniel Molin

Research Interests

Explore related searches

Contact this professor

Articles (10)

Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma

Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway—A population‐based matched cohort study

Five-year follow-up of KEYNOTE-087

Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial.

NLPHL: a hummingbird in an owl's nest.

Checkpoint CD47 expression in classical Hodgkin lymphoma

An image registration method for voxel-wise analysis of whole-body oncological PET-CT.

Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls.

Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity.

Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy.

Collaborators (8)

Joshua Philipp Entrop

Ingrid Glimelius

Rose-Marie Amini

Sara Ek

Harald Holte

John Radford

Anna Porwit

Martin Hutchings

Make your next move.